New AI Blood Test Detects Silent Liver Disease Before Symptoms Appear

Johns Hopkins researchers built an AI blood test that reads genome-wide cell-free DNA fragmentation patterns.

In a study of 1,576 people, it detected early liver disease, advanced fibrosis, and cirrhosis with high sensitivity.

The liquid biopsy could help find silent, reversible liver disease much earlier, before symptoms appear.

Earlier diagnosis may improve treatment timing and help prevent progression to cirrhosis and liver cancer.